GAME Veterans With PTSD Using Computer-Based Cognitive Training
Enhancing Cognitive Function and Reintegration in Iraq and Afghanistan Veterans With PTSD Using Computer-Based Cognitive Training
1 other identifier
interventional
25
1 country
1
Brief Summary
The investigators hypothesis are as follows: H1a: OEF/OIF veterans with PTSD who perform cognitive training (CT) will demonstrate greater objective improvements on standard (untrained) neurocognitive measures, with the largest gains in verbal memory, learning and sustained attention. H1b: Objective cognitive improvements in CT participants will be sustained at three months post-intervention, suggesting persistence of neuroplasticity-based cognitive training benefits. H2a: OEF/OIF veterans with PTSD who perform CT will report greater improvements in cognitive function. H2b: OEF/OIF veterans with PTSD who perform CT will demonstrate improved social and occupational functioning and quality of life. H2c: OEF/OIF veterans with PTSD who perform CT will demonstrate greater improvements in community reintegration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2010
CompletedFirst Posted
Study publicly available on registry
March 16, 2010
CompletedStudy Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedResults Posted
Study results publicly available
December 5, 2019
CompletedDecember 23, 2019
December 1, 2019
4.4 years
March 15, 2010
April 16, 2018
December 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change Scores of Standard (Untrained) Neurocognitive Measures (Verbal Memory, Learning and Sustained Attention)
We presented change scores (6-month scores minus baseline scores) outcomes of 10 measures of neurocognitive measures (together with ranges): the Wechsler Memory Scale (WMS-IV) Paired Associates immediate and delayed memory (range: 1-19), Rey Auditory Verbal Learning Test (RAVLT) total score (range: 0-100) and delayed score (range: 0-20), Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span (range: 0-48), Wechsler Adult Intelligence Scale (WAIS-IV) Letter Number Sequencing (range: 1-19), Auditory Consonant Trigrams (ACT) raw score (range: 0-60), Delis-Kaplan Executive Function System (D-KEFS) Stroop Inhibition (range: 1-19), and the Brief Visual Memory Test revised (BVMT-R) total T score and Delayed T score (range: 20-80). Higher scores mean better cognitive functioning outcomes.
6-month follow-up
Secondary Outcomes (1)
Social and Occupational Functioning and Quality of Life Scores at 6 Months
6 month follow-up
Study Arms (1)
Cognitive Training
EXPERIMENTALPlasticity Based Adaptive Cognitive Remediation (PACR)
Interventions
Plasticity Based Adaptive Cognitive Remediation (PACR)
Eligibility Criteria
You may qualify if:
- An experienced clinical interviewer with Master's-level training will conduct first- and second-level screening to determine study eligibility for enrollment in the randomized controlled trial.
- Confirmed OEF and/or OIF military service
- Male veterans, ages 18 to 40 years with 12 to 16 years of education
- History of a prior positive PTSD screen or diagnosis either by SFVAMC study referral or self-report'
- Able and willing to travel to SFVAMC
- Able and willing to perform daily home-based computer exercises for three months.
- The Second Level Eligibility Determination will occur in-person at the SFVAMC of potential participants who have met first-level screening eligibility criteria. Second-level eligibility screening will require signed informed consent (see below) before the second-level screening is conducted. During the second-level eligibility screen, consenting participants will be administered:
- The Clinician-Administered PTSD screen (CAPS) and the Mini International Neuropsychiatric Interview (MINI) 29 to assess for Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorders
- The VA TBI second-level screen \[TBI event history and Neurobehavioral Symptom Inventory (NSI) for cognitive symptoms\].30
- To be eligible for enrollment in the randomized controlled, veterans at second-level screening must:
- Meet threshold criteria for current full or sub-syndromal PTSD by DSM-IV criteria 31
- Report ≥ 1 moderate or severe cognitive symptom(s) on the NSI that interfere(s) with daily function including moderate to severe poor concentration, forgetfulness, difficulty making decisions and slowed thinking.
- Because PTSD is a highly comorbid condition, eligible participants may have other comorbid stable neuropsychiatric disorders, including depression or a history of a mild traumatic brain injury.
You may not qualify if:
- Poor English comprehension and fluency
- Unstable medical condition, injury or disability, including moderate to severe TBI (by self-report) and hearing impairment
- Current (or past 60 day) evidence-based PTSD or cognitive remediation therapy; in contrast, stable supportive therapy for PTSD and/or other mental disorders, such as group therapy or on stable psychoactive medication (\> 30 days) will be acceptable.
- Drug and alcohol dependence and other unstable serious mental illness (e.g. psychosis) (assessed using the MINI)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karen Seallead
Study Sites (1)
San Francisco Veterans Affairs Medical Center
San Francisco, California, 94121, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Karen Seal
- Organization
- San Francisco VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Karen H Seal, MD
San Francisco VA Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
March 15, 2010
First Posted
March 16, 2010
Study Start
April 1, 2010
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
December 23, 2019
Results First Posted
December 5, 2019
Record last verified: 2019-12